Methods for diagnosing and evaluating cancer
US6682901B2 · kind B2 · utility
33Cited by
8References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 5, 1999 |
| Grant date | Jan 27, 2004 |
| Priority date | — |
| Expiry date | May 5, 2019 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S977/915
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods for diagnosing cancer, such as prostate, ovarian or breast cancer, as well as leukemia, are provided. Such methods may employ binding agents, such as antibodies or CAR sequences of OB-cadherin or N-cadherin, that specifically bind to OB-cadherin or N-cadherin, or polynucleotides that hybridize to a polynucleotide encoding OB-cadherin or N-cadherin. Also provided are methods for monitoring the progression of a cancer and to evaluate the metastatic potential of a cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.